Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Hendrik Peter Scholl is Chief Medical Officer at Belite Bio. OQRO lists 22 transactions filed with the SEC under this name, the latest on Oct 6, 2026, each linked to the official Form 4.
Chief Medical Officer
Disclosures on record
22
Companies involved
1
Belite BioBLTE
22 disclosures · Apr 2026 – Oct 2026 · 21 sold
Oct 1, 2026Sold~$33Kdisclosed Oct 6
DetailsOfficial recordOct 1, 2026Sold~$20Kdisclosed Oct 6
DetailsOct 1, 2026Sold~$13Kdisclosed Oct 6
DetailsOfficial recordOct 1, 2026Sold~$8.3Kdisclosed Oct 6
DetailsOfficial recordOct 1, 2026Sold~$4Kdisclosed Oct 6
DetailsOfficial recordOct 1, 2026Sold~$2Kdisclosed Oct 6
DetailsOfficial recordOct 1, 2026Sold~$2.4Kdisclosed Oct 6
DetailsOfficial recordOct 1, 2026Sold~$340disclosed Oct 6
DetailsOfficial recordJun 18, 2026Sold~$707Kdisclosed Jun 22
DetailsOfficial recordJun 18, 2026Sold~$542Kdisclosed Jun 22
DetailsOfficial recordJun 18, 2026Sold~$175Kdisclosed Jun 22
DetailsOfficial recordJun 18, 2026Sold~$14Kdisclosed Jun 22
DetailsOfficial recordJun 18, 2026Sold~$14Kdisclosed Jun 22
DetailsOfficial recordJun 16, 2026Sold~$438Kdisclosed Jun 17
DetailsOfficial recordJun 16, 2026Sold~$283Kdisclosed Jun 17
DetailsOfficial recordJun 16, 2026Sold~$272Kdisclosed Jun 17
DetailsOfficial recordJun 16, 2026Sold~$150Kdisclosed Jun 17
DetailsOfficial recordJun 16, 2026Sold~$108Kdisclosed Jun 17
DetailsOfficial recordJun 16, 2026Sold~$76Kdisclosed Jun 17
DetailsOfficial recordJun 16, 2026Sold~$64Kdisclosed Jun 17
DetailsOfficial recordJun 16, 2026Sold~$14Kdisclosed Jun 17
DetailsOfficial recordApr 21, 202610Kdisclosed Apr 24
DetailsOfficial recordAs of the latest filing on , Hendrik Peter Scholl reported holding 14,500 shares of Belite Bio (BLTE), worth about $2.38M at the last close of $164 (Nov 13, 2026), held through a bioptima ltd. In the last 12 months, Hendrik Peter Scholl sold $2.94M in 21 sales.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Belite Bio BLTE | 14,500 | 15K bioptima ltd | $164 | $2.38M | Oct 1, 2026 |
Is this Hendrik Peter Scholl’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Oct 1, 2026, Hendrik Peter Scholl reported holding 14,500 shares of Belite Bio (BLTE), held indirectly. At the last close of $164 on Nov 13, 2026, that is about $2.38M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Hendrik Peter Scholl reported 21 open-market sales worth $2.94M, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Hendrik Peter Scholl has no open-market purchase on record since 2026. Sales in 1 of the 1 years since 2026.
In SEC filings since 2026: no open-market purchase is on record; the latest open-market sale is from 2026.
Belite Bio (BLTE), from 2026 to 2026: 0 purchases and 21 sales.
Hendrik Peter Scholl has no open-market purchase on record since 2026. Sales in 1 of the 1 years since 2026.
Hendrik Peter Scholl reported 0 open-market purchases and 21 sales since 2026; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $2.94M21×21 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Hendrik Peter Scholl reported 0 open-market purchases and 21 sales here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.